MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

AXGN — Axogen, Inc. Common Stock

Nasdaq

Axogen, Inc. Common Stock

Back to Screener
$37.39
-2.53(-6.34%)
O
39.92
H
39.92
L
36.97
V
3.06M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About AXGN

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateDec 17, 1986
Employees622
Stock ExchangeNasdaq
Ticker SymbolAXGN

Key Financial Statistics

Market Cap$2.55B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$15.27 - $52.91
52-Week Avg Volume1.06M
VWAP$37.88
Transactions38,908
Total Recorded Bars9,244 days